Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mexico-US Collaboration Launched

21.01.2010
Mexico-US collaboration launched to study major human diseases / Carlos Slim Institute of Health to fund genomic research on cancer, type 2 diabetes, and a form of kidney disease

Mexican business leader Carlos Slim Helú today announced the launch of a major research project in genomic medicine that will help accelerate progress in public health in Mexico and around the world.

The project will be carried out by the Carlos Slim Institute of Health in partnership with the Broad Institute of MIT and Harvard and the National Institute for Genomic Medicine of the Mexican Secretariat of Health. The major goal is to understand the genomic basis of cancer in worldwide populations and of type 2 diabetes in Mexican and Latin American populations.

The project, called Slim Initiative for Genomic Medicine, will last three years and will receive US $65M in support from the Carlos Slim Institute of Health. It will leverage the Broad Institute’s expertise and capabilities in the most advanced technologies in genomic sequencing.

The project also involves the training of Mexican experts under the leadership of the National Institute of Genomic Medicine of the Mexican Secretariat of Health, the leading institution in genomic research in Latin America.

The findings of this research will help accelerate both the prevention of disease as well as the development of improved therapies in Mexico and beyond.

Referring to the importance of the project, Carlos Slim said, “I am convinced that only through genomics will we be able to face the costly burden of illnesses that strain the budgets of even the richest countries.”

“Carlos Slim is making a visionary commitment to public health in the Americas in two ways,” said Dr. Eric S. Lander, director and president of the Broad Institute of MIT and Harvard. “First, in recognizing that progress in public health must be built on a foundation of scientific understanding of the genetic basis of disease. Second, in recognizing that deepening the scientific ties between the US and Mexico can have great benefits for both countries. We look forward to making common cause with our colleagues in Mexico.”

The research project will make use of new technologies for decoding or “sequencing” DNA, which have made it possible for researchers to study DNA more rapidly and at a lower cost than ever before. In cancer, the scientists will create catalogs of the genetic abnormalities (called “mutations”) that occur across different cancer types. Such knowledge aims to reveal key genetic weaknesses that can be exploited by new cancer therapies and to identify which patients are most likely to respond to specific cancer drugs.

In type 2 diabetes, the researchers will also assemble systematic descriptions of the genetic factors underlying the disease, with a special focus on Latin American populations. Diabetes is among the most common inherited diseases in Latin America, yet a deep knowledge of the genetic risk factors in the region’s populations is lacking. A profound understanding of these factors is needed in order to foster prevention, treatment and control.

During the three years of the project, major findings will be publicly announced. In order to guarantee that the project benefits science and the population in general, the main recipient of its findings will be the National Institute for Genomic Medicine.

To supervise the scientific progress of the project a Scientific Advisory Board has been established. It is composed of renowned scientists from around the world with vast experience in the fields of cancer, diabetes, and genomic science.

The Scientific Advisory Board members include (in alphabetical order):

Carlos Bustamante
Professor, Department of Genetics, Stanford School of Medicine
Thomas Hudson
President and Scientific Director of Ontario’s Institute for Cancer Research
Gerardo Jiménez Sánchez
Professor of genomic medicine at the National Autonomous University of Mexico, Advisor to the OECD’s Working Group on Biotechnology and Scientific Director of BioFields
David Nathan
Director of the Center of Diabetes and Director of the Center for General Clinical Research, Massachusetts General Hospital
Guillermo Ruiz Palacios
Head of the Infection Diseases Department of the Salvador Zuribán National Institute of Medical Sciences and Nutrition, Mexican Secretariat of Health
Xavier Soberón
General Director of the National Institute of Genomic Medicine, Mexican Secretariat of Health
About the Broad Institute of MIT and Harvard
The Eli and Edythe L. Broad Institute of MIT and Harvard was founded in 2003 to empower this generation of creative scientists to transform medicine with new genome-based knowledge. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods, and data openly to the entire scientific community.

Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff, and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to www.broadinstitute.org.

About the Carlos Slim Health Institute
The Carlos Slim Health Institute was created in 2007 by the initiative of Mr. Carlos Slim Helú for the development and funding of programs aimed at contributing to the solution of the principal health problems in Latin America and the Caribbean under an innovative and human spirit and with a clear concern for the neediest populations.

The Institute contributes to cover the demand of services by spurring the creation of primary health care units; it also facilitates the approximation of health resources to the population via communication technology that serves as information, accompaniment and contact means, and through leading-edge educational communication actions it also encourages people and populations to participate in their own welfare.

In addition, the Institute also provides support to other not-for-profit organizations that promote people’s welfare by favoring their physical health, a proper household as well as natural and community environments.

Ultimately, the Institute encourages health knowledge through grants for students and professionals; awards for leading applied-sciences researchers and institutions, and through the generation of innovative and reliable information for national decision makers. The Carlos Slim Institute works day after day with a single goal: help people live longer and better.

www.salud.carso.org

About the National Institute of Genomic Medicine
The National Institute of Genomic Medicine (INMEGEN), is the eleventh National Institute of Health in Mexico, founded in 2004. INMEGEN´s mission is to contribute to the health care of the Mexican population by developing cutting-edge scientific research and well-trained human resources in order to apply the knowledge of genomic medicine through innovation, state-of-the-art technology, and strategic partnerships, all the while complying with universal ethical principles.

INMEGEN´s main research areas focus on principal complex diseases in Mexico, including population genomics of the Mexican population, genomics of metabolic diseases (diabetes mellitus and obesity), cancer, infectious diseases, cardiovascular diseases, nutrigenomics, and pharmacogenomics.

One of the features of INMEGEN’s innovative culture is scientific research and development of technology, which leads to goods and services, that can then be used to contribute to better health care for the Mexican people in the knowledge-based economy.

www.inmegen.gob.mx

Nicole Davis | Newswise Science News
Further information:
http://www.broadinstitute.org

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>